Reprogramming of peripheral blood mononuclear cells from a patient with hypophosphatasia to generate iPSC line (UOMi011-A)

Abstract

Hypophosphatasia (HPP) is a rare inherited metabolic disorder predominantly affecting bones and teeth. HPP can manifest throughout the life cycle from in utero, to perinatal and infantile (before 6 months of age) presentations, to onset in childhood through adulthood. We report a new cell line (UOMi011-A) generated from a 7 yr. old female with perinatal HPP. The patient exhibits homozygous c.1001G > A (p.Gly334Asp) mutation in the ALPL gene. This cell line will be used for studying the molecular, cellular and developmental mechanisms in context to the mutation and disorder. It will also be used to screen potential therapeutic avenues.